The business of biomedical research is mostly about failure. Few projects we commission will ultimately result in success. But every study we do contributes to the body of knowledge that brings science and society closer to a solution.

The business of biomedical research is
The business of biomedical research is
The business of biomedical research is mostly about failure. Few projects we commission will ultimately result in success. But every study we do contributes to the body of knowledge that brings science and society closer to a solution.
The business of biomedical research is
The business of biomedical research is mostly about failure. Few projects we commission will ultimately result in success. But every study we do contributes to the body of knowledge that brings science and society closer to a solution.
The business of biomedical research is
The business of biomedical research is mostly about failure. Few projects we commission will ultimately result in success. But every study we do contributes to the body of knowledge that brings science and society closer to a solution.
The business of biomedical research is
The business of biomedical research is mostly about failure. Few projects we commission will ultimately result in success. But every study we do contributes to the body of knowledge that brings science and society closer to a solution.
The business of biomedical research is
The business of biomedical research is mostly about failure. Few projects we commission will ultimately result in success. But every study we do contributes to the body of knowledge that brings science and society closer to a solution.
The business of biomedical research is
The business of biomedical research is
The business of biomedical research is
The business of biomedical research is
The business of biomedical research is
The business of biomedical research is

The quote by Kenneth Frazier, "The business of biomedical research is mostly about failure. Few projects we commission will ultimately result in success. But every study we do contributes to the body of knowledge that brings science and society closer to a solution," highlights the inherent challenges and importance of failure in the field of scientific research. Frazier emphasizes that while the outcome of many biomedical studies may not lead to immediate success, the knowledge gained through each study plays a crucial role in advancing the scientific community and bringing us closer to meaningful solutions for health and society.

The origin of this quote stems from Frazier’s leadership in the pharmaceutical industry, where he has been a key figure in the research and development of medications and treatments. As the CEO of Merck & Co., Frazier has firsthand experience with the complexities of biomedical research, which is often filled with trial, error, and failure. His statement reflects the understanding that failure is an integral part of the scientific process and that each failed attempt contributes to the broader goal of finding effective treatments or cures.

Frazier’s words also underline the importance of perseverance in biomedical research. Although many projects do not lead to immediate success, the collective knowledge gained from multiple studies helps to advance science and bring new insights into potential solutions. His quote encourages researchers to view failure not as a dead-end but as a necessary part of the iterative process that eventually leads to breakthroughs. The business of research is long-term and requires ongoing commitment to discovery and learning.

In essence, this quote emphasizes the value of failure in scientific progress and how each step, even if it doesn’t lead to immediate success, contributes to the larger body of knowledge. Frazier’s statement serves as a reminder that in fields like biomedical research, every study, whether successful or not, plays a vital role in moving science and society toward meaningful solutions, showing that failure is not an end but a part of the journey.

Kenneth Frazier
Kenneth Frazier

American - Businessman Born: December 17, 1954

Have 0 Comment The business of biomedical research is

AAdministratorAdministrator

Welcome, honored guests. Please leave a comment, we will respond soon

Reply.
Information sender
Leave the question
Click here to rate
Information sender
0.22712 sec| 2549.453 kb